An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer

1999-08-26

Anti-Cancer Drugs , Volume 10 - Issue 3 p. 283- 288

Additional Metadata
Keywords	Advanced colorectal cancer, Chemotherapy, Economic evaluation, Palliation, Thymidylate synthase inhibitor, Tomudex
Persistent URL	doi.org/10.1097/00001813-199903000-00005, hdl.handle.net/1765/70462
Journal	Anti-Cancer Drugs
Organisation	Erasmus School of Health Policy & Management (ESHPM)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Groener, M. G. H., van Ineveld, M., Byttebier, G., van Hout, B., & Rutten, F. (1999). An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer. Anti-Cancer Drugs, 10(3), 283–288. doi:10.1097/00001813-199903000-00005

Publication